{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:11:03Z","timestamp":1791875463367,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","geriatriconcology.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jgo.2023.101506","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:25:47Z","timestamp":1684499147000},"page":"101506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70\u00a0years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08\u201302 study"],"prefix":"10.1016","volume":"15","author":[{"given":"S\u00e9bastien","family":"Gendarme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Zebachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Greillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Justeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bylicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Decroisette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Auliac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Guisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ricordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Frelaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Paillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Choua\u00efd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Canou\u00ef-Poitrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2023.101506_bb0005","unstructured":"Source: ECIS - European Cancer Information System From https:\/\/ecis.jrc.ec.europa.eu, accessed on 28\/07\/2022 \u00a9 European Union, 2023 n.d."},{"key":"10.1016\/j.jgo.2023.101506_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/annonc\/mdu022","article-title":"Management of elderly patients with NSCLC; updated expert\u2019s opinion paper: EORTC elderly task force, lung cancer group and international society for geriatric oncology","volume":"25","author":"Pallis","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11864-011-0161-5","article-title":"Basic assessment of the older cancer patient","volume":"12","author":"Extermann","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0025","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration","volume":"22","author":"Talarico","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0030","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2023.101506_bb0035","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2023.101506_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2023.101506_bb0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1200\/JCO.2016.69.3143","article-title":"Performance of four frailty classifications in older patients with cancer: prospective elderly cancer patients cohort study","volume":"35","author":"Ferrat","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0050","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2015.63.5839","article-title":"Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study","volume":"34","author":"Corre","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2023.101506_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2018.04.013","article-title":"Predicting early death in older adults with cancer","volume":"100","author":"Boulahssass","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgo.2023.101506_bb0070","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2023.101506_bb0075","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jgo.2020.10.013","article-title":"The predictive value of G8 and the cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer","volume":"12","author":"Chan","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"suppl; abstr 12050","key":"10.1016\/j.jgo.2023.101506_bb0085","article-title":"External validation of two predictive scores of chemotherapy toxicities among older patients with solid cancer, from ELCAPA prospective cohort. ASCO annual meeting","volume":"38","author":"Maxime Frelaut","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0090","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jgo.2023.101506_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.jgo.2023.101506_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jgo.2023.101506_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1040-8428(00)00090-1","article-title":"Measurement and impact of comorbidity in older cancer patients","volume":"35","author":"Extermann","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jgo.2023.101506_bb0110","first-page":"91","article-title":"Development and contribution to the validation of a brief French version of the Yesavage Geriatric Depression Scale","volume":"23","author":"Cl\u00e9ment","year":"1997","journal-title":"Encephale"},{"key":"10.1016\/j.jgo.2023.101506_bb0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cup & go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2023.101506_bb0120","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3143\/geriatrics.53.387","article-title":"Association between the nutritional status and the severity of sarcopenia among community-dwelling elderly Japanese people","volume":"53","author":"Komai","year":"2016","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.jgo.2023.101506_bb0130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/ndt\/17.11.1909","article-title":"Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation","volume":"17","author":"Vervoort","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jgo.2023.101506_bb0135","series-title":"Diagnosis of malnutrition in people aged 70 and over. Saint-Denis La Plaine","author":"Haute Autorit\u00e9 de Sant\u00e9 HAS","year":"2021"},{"key":"10.1016\/j.jgo.2023.101506_bb0140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jgo.2023.101506_bb0145","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.2011.35.7442","article-title":"Predictors of early death risk in older patients treated with first-line chemotherapy for cancer","volume":"30","author":"Soubeyran","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0150","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.21037\/jtd.2017.09.51","article-title":"Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC group","volume":"9","author":"Le Caer","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jgo.2023.101506_bb0155","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12885-020-06878-2","article-title":"Impact of the comprehensive geriatric assessment on treatment decision in geriatric oncology","volume":"20","author":"Sourdet","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2023.101506_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cllc.2016.05.007","article-title":"Relevance of a geriatric assessment for elderly patients with lung cancer-a systematic review","volume":"17","author":"Schulkes","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jgo.2023.101506_bb0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12094-007-0019-2","article-title":"Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine","volume":"9","author":"Maestu","year":"2007","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0170","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1002\/cam4.3205","article-title":"Geriatric assessment domains to predict overall survival in older cancer patients: an analysis of functional status, comorbidities, and nutritional status as prognostic factors","volume":"9","author":"Morishima","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jgo.2023.101506_bb0175","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jgo.2019.02.004","article-title":"Functional status in a geriatric oncology setting: a review","volume":"10","author":"Couderc","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0180","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1200\/OP.20.01004","article-title":"Functional disability among older versus younger adults with advanced non-small-cell lung cancer","volume":"17","author":"Presley","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jgo.2023.101506_bb0185","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1634\/theoncologist.2012-0186","article-title":"The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer","volume":"17","author":"Hamaker","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2023.101506_bb0190","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1200\/JCO.2004.08.040","article-title":"Differential prognostic impact of comorbidity","volume":"22","author":"Read","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0195","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2011.39.5269","article-title":"Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans","volume":"30","author":"Wang","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jgo.2013.02.002","article-title":"Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer","volume":"4","author":"Wildes","year":"2013","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3390\/cancers14051344","article-title":"Measuring walking speed failed to predict early death and toxicity in elderly patients with metastatic non-small-cell lung cancer (NSCLC) selected for undergoing first-line systemic treatment: an observational exploratory study","volume":"14","author":"Aregui","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jgo.2023.101506_bb0210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jgo.2015.02.005","article-title":"Estimating the risk of chemotherapy toxicity in older patients with cancer: the role of the vulnerable elders survey-13 (VES-13)","volume":"6","author":"Luciani","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0215","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1200\/JCO.2012.42.9894","article-title":"Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients","volume":"31","author":"Aparicio","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0220","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/annonc\/mdi368","article-title":"Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study","volume":"16","author":"Freyer","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0225","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jgo.2018.06.007","article-title":"Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age","volume":"10","author":"Ruiz","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jgo.2013.12.004","article-title":"Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy","volume":"5","author":"Baitar","year":"2014","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2023.101506_bb0235","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.clnu.2022.02.016","article-title":"Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: the ELCAPA-25 prospective cohort survey","volume":"41","author":"Boudou-Rouquette","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jgo.2023.101506_bb0240","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1186\/s12885-019-6377-7","article-title":"Low lean mass and chemotherapy toxicity risk in the elderly: the fraction study protocol","volume":"19","author":"Steinmeyer","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2023.101506_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejca.2017.06.027","article-title":"Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer","volume":"83","author":"Martinez-Tapia","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgo.2023.101506_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2020.100042","article-title":"A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS study","volume":"6","author":"Gomes","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.jgo.2023.101506_bb0255","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jgo.2019.05.021","article-title":"Geriatric assessment and treatment outcomes in older adults with cancer receiving immune checkpoint inhibitors","volume":"11","author":"Welaya","year":"2020","journal-title":"J Geriatr Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T13:25:51Z","timestamp":1722086751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406823001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1879406823001030"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101506","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70\u00a0years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08\u201302 study","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101506"}}